| Open Document File Size: 402,97 KBShare Result on Facebook
Company Bayer / / Continent North America / / Event Product Issues / Product Recall / / IndustryTerm treatment of von Willebrand’s disease / venous access device / rubber / manufacturing process / final product / treatment of hemophilia / / MedicalCondition Administration Site Conditions Immune System Disorders Preferred Term FVIII inhibition Pruritus / HIV / hives / nausea / anaphylaxis / immediate hypersensitivity / infectious / severe hypersensitivity / fatigue / injury / rash Infusion site reaction Pyrexia Anaphylactic reaction / serious allergic/hypersensitivity / skin and subcutaneous tissue disorders general disorders / Head trauma / tachycardia / hypersensitivity / restlessness / hepatitis / pruritus / infections / hemophilia / wheezing / hypotension / hemophilia A / flushing / dyspnea / shortness of breath / Carcinogenesis / CJD / VIII deficiency / vomiting / pain / von Willebrand’s disease / urticaria / transmissible spongiform encephalopathy / AIDS / dizziness / cough / inflammation / hemarthroses / rash / severe hemophilia A / / MedicalTreatment emergency treatment / surgery / Central venous catheterization / catheter / major surgery / total knee replacement / / Movie Half-life / / Organization World Health Organization / Intravenous administration / DOSAGE AND ADMINISTRATION / FDA / / Person Disorders Pyrexia / / / Position physician / General / treating physician / Major / / Product BU / FS / Calcium Chloride / Glycine / / Technology antibodies / Pharmacokinetics / ion exchange / Pharmacodynamics / recombinant DNA technology / / URL www.fda.gov/medwatch / /
SocialTag |
Kogenate FS Package Insert